<div id="readability-page-1"><p>Bayer Aktiengesellschaft reported earnings results for the third quarter and nine months ended September 30, 2025. For the third quarter, the company reported sales was EUR 9,660 million compared to EUR 9,968 million a year ago. Net loss was EUR 963 million compared to EUR 4,183 million a year ago. Basic loss per share from continuing operations was EUR 0.98 compared to EUR 4.26 a year ago. Diluted loss per share from continuing operations was EUR 0.98 compared to EUR 4.26 a year ago.<br/> For the nine months, sales was EUR 34,137 million compared to EUR 34,877 million a year ago. Net income was EUR 137 million compared to net loss of EUR 2,217 million a year ago. Basic earnings per share from continuing operations was EUR 0.14 compared to basic loss per share from continuing operations of EUR 2.26 a year ago. Diluted earnings per share from continuing operations was EUR 0.14 compared to diluted loss per share from continuing operations of EUR 2.26 a year ago.</p></div>

拜耳

拜耳(ADR)

<p>拜耳 Aktiengesellschaft 公佈了 2025 年第三季度及前九個月的財報。第三季度銷售額為 96.6 億歐元，同比下降自 99.68 億歐元，淨虧損為 9.63 億歐元，而去年為虧損 41.83 億歐元。在前九個月，銷售總額為 341.37 億歐元，略低於去年的 348.77 億歐元，但淨收入改善至 1.37 億歐元，而去年為虧損 22.17 億歐元。持續經營業務的基本和稀釋每股收益為 0.14 歐元，較去年虧損 2.26 歐元有所恢復</p>

拜耳股份公司公佈了截至2025年9月30日的第三季度及九個月的財務業績